| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.7M | $3.6M | $4.1M |
| YoY Revenue Growth % | +1.8% | -12.4% | — |
| Gross Profit | $2.0M | $3.0M | — |
| Gross Margin % | 54.5% | 82.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$573.0M | -$186.0M | -$16.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | $0 | -$400.9M | -$58.2M |
| EBITDA (Normalized) | -$572.6M | -$182.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $14.8M | -$61.0M | -$9.7M |
| Capital Expenditures (CapEx) | $573.5K | $5.0M | — |
| Free Cash Flow (FCF) | $14.2M | -$66.0M | -$9.7M |
| FCF Margin % | 80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -29.9% | -19.8% | — |
| Cash & Short-Term Equivalents | $134.6M | $170.2M | — |
| Total Debt (Short + Long Term) | $442.6K | — | — |
| Total Stockholders' Equity | $1.65B | $913.6M | — |